Associations between reduced GR expression and unfavorable tumor features have also been described for adrenocortical carcinomas [50], thymic epithelial tumors [62], ductal adenocarcinoma of the pancreas [42], cervical cancer [56], colorectal adenocarcinomas, and non-small cell lung cancer [45]. The gene discussed is NR3C1; the disease is adrenal cortex carcinoma.